EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence in Prostate MRI: Current Evidence and Clinical Translation Challenges—A Narrative Review

Vlad-Octavian Bolocan, Alexandru Mitoi, Oana Nicu-Canareica, Maria-Luiza Băean, Cosmin Medar iD, Gelu-Adrian Popa

Journal of Imaging · 26.09.2025 · 11 (10) · 335

DOI: 10.3390/jimaging11100335 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Imaging, online erschienen am 26.09.2025. Verfasst von Vlad-Octavian Bolocan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program Studies, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite rapid proliferation of AI applications in prostate MRI showing impressive technical performance, clinical adoption remains limited. We conducted a comprehensive narrative review of literature from January 2018 to December 2024, examining AI applications in prostate MRI with emphasis on real-world performance and implementation challenges. Among 200+ studies reviewed, AI systems achieve 87% sensitivity and 72% specificity for cancer detection in research settings. However, external validation reveals average performance drops of 12%, with some implementations showing degradation up to 31%. Only 31% of studies follow reporting guidelines, 11% share code, and 4% provide model weights. Seven real-world implementation studies demonstrate integration times of 3–14 months, with one major center terminating deployment due to unacceptable false positive rates. The translation gap between artificial and clinical intelligence remains substantial. Success requires shifting focus from accuracy metrics to patient outcomes, establishing transparent reporting standards, developing realistic economic models, and creating appropriate regulatory frameworks. The field must combine methodological rigor, clinical relevance, and implementation science to realize AI’s transformative potential in prostate cancer care.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceclinical implementationdeep learningdiagnostic imagingmagnetic resonance imagingnarrative reviewprostate cancerradiomics

Autor:innen und Institutionen

  • Doctoral Program Studies, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
  • Department of Fundamental Sciences, Faculty of Midwifery and Nursing, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
  • Clinical Laboratory of Radiology and Medical Imaging, Clinical Hospital "Prof. Dr. Theodor Burghele", 050664 Bucharest, Romania.
  • Department of Laboratory of Radiology and Medical Imaging, SF. Ioan Clinical Emergency Hospital, 042122 Bucharest, Romania.

ORCID-Profile: Cosmin Medar

Zitieren

APA

Bolocan, V. O., Mitoi, A., Nicu-Canareica, O., Băean, M. L., Medar, C., & Popa, G. A. (2025). Artificial Intelligence in Prostate MRI: Current Evidence and Clinical Translation Challenges—A Narrative Review. Journal of Imaging, 11(10), 335. https://doi.org/10.3390/jimaging11100335

Vancouver

Bolocan VO, Mitoi A, Nicu-Canareica O, Băean ML, Medar C, Popa GA. Artificial Intelligence in Prostate MRI: Current Evidence and Clinical Translation Challenges—A Narrative Review. Journal of Imaging. 2025;11(10):335. doi:10.3390/jimaging11100335

BibTeX
@article{Bolocan2025,
  author = {Bolocan, Vlad-Octavian and Mitoi, Alexandru and Nicu-Canareica, Oana and Băean, Maria-Luiza and Medar, Cosmin and Popa, Gelu-Adrian},
  title = {Artificial Intelligence in Prostate MRI: Current Evidence and Clinical Translation Challenges—A Narrative Review},
  journal = {Journal of Imaging},
  year = {2025},
  volume = {11},
  number = {10},
  pages = {335},
  doi = {10.3390/jimaging11100335}
}
Kostenlos starten →